Annual Report 2007 The Nerve Research Foundation The University of Sydney Institute of Clinical Neurosciences Royal Prince Alfred Hospital

First Page		Document Content
Date: 2008-07-24 01:21:50 Neurological disorders Peripheral neuropathy Myelin Royal Prince Alfred Hospital Guillain–Barré syndrome Motor neurone disease John D. Pollard Health Anatomy Autoimmune diseases		Annual Report 2007 The Nerve Research Foundation The University of Sydney Institute of Clinical Neurosciences Royal Prince Alfred Hospital Add to Reading List Source URL: pandora.nla.gov.au Download Document from Source Website File Size: 948,34 KB Share Document on Facebook

	ISOFENPHOS Isofenphos is rated by the EPA as a highly toxic organophosphate and capable of altering function of the brain, peripheral nerves and autonomic nerves.1 It is capable of causing delayed neuropathy in mammal DocID: 1srMF - View Document
	Original Article Journal of CLINICAL NEUROMUSCULAR DocID: 1rfku - View Document
	Microsoft Word - Fact Sheet on Botulism Following Botulinum Toxin Injection_16 DocID: 1r752 - View Document
	Regulation of Spinal Fractalkine/CX3CR1 and TNF-alpha Signaling in Paclitaxel Induced Peripheral Neuropathy in Rats Chemotherapy-induced peripheral neuropathy (CIPN) is a common, potentially severe and dose-limiting adve DocID: 1qSei - View Document
	Neural Sensitization: The Medical Key to Treatment for Chemical Injury Science Based Treatment INTRODUCTION Chemical injury can cause chronic damage to body biochemistry. This involves a biochemical vicious cycle often c DocID: 1pCTO - View Document